Cargando…

SAT-567 Hypertriglyceridem...From Mild to Fatal!... Is Time for Awareness

Hypertriglyceridemia… From mild to fatal! … Is Time for Awareness. Hypertriglyceridemia can be primary or acquired. High triglycerides are related to complications such as pancreatitis and there is a positive correlation between hypertriglyceridemia and atherosclerotic burden. In this case series we...

Descripción completa

Detalles Bibliográficos
Autores principales: Cruz, Alegyari Figueroa, Marin, Luis N Madera, Ocasio, Lisselle M Villarrubia, Molina Torres, Edwin O, Irizarry De Jesus, Dariel J, Rios, Alba D Rivera, Vives, Alejandra N Santiago, Bossolo, Alex N Gonzalez
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207433/
http://dx.doi.org/10.1210/jendso/bvaa046.014
_version_ 1783530604119195648
author Cruz, Alegyari Figueroa
Marin, Luis N Madera
Ocasio, Lisselle M Villarrubia
Molina Torres, Edwin O
Irizarry De Jesus, Dariel J
Rios, Alba D Rivera
Vives, Alejandra N Santiago
Bossolo, Alex N Gonzalez
author_facet Cruz, Alegyari Figueroa
Marin, Luis N Madera
Ocasio, Lisselle M Villarrubia
Molina Torres, Edwin O
Irizarry De Jesus, Dariel J
Rios, Alba D Rivera
Vives, Alejandra N Santiago
Bossolo, Alex N Gonzalez
author_sort Cruz, Alegyari Figueroa
collection PubMed
description Hypertriglyceridemia… From mild to fatal! … Is Time for Awareness. Hypertriglyceridemia can be primary or acquired. High triglycerides are related to complications such as pancreatitis and there is a positive correlation between hypertriglyceridemia and atherosclerotic burden. In this case series we aim to discuss pancreatitis as a hypertriglyceridemia complication and to acknowledge the importance of prevention and management. Is there something we can do to raise awareness and avoid complications as in the cases? All cases present with chief complaint of epigastric cramp-like abdominal pain, radiating to the back, nausea/vomiting and with highly lipemic blood samples. 38y/o F admitted after been found with lipase 268 U/L (n<60 U/L), amylase 131 U/L (n<100 U/L) and findings of pancreatitis on CT scan. Patient with one-year history of T2DM refers this is the 4(th) episode of pancreatitis and reports that last time she was told about having triglycerides in 4,000 mg/dL for which she went to her physician that prescribe her Fenofibrate. Patient triglycerides were 7,931 mg/dL (n<199 mg/dL) and found with poorly controlled diabetes with HgbA1c 8.4%. She was properly managed, and triglycerides decrease to 1,309 mg/dL. 31y/o F with elevated lipase (237 U/L, n<60 U/L) and findings of pancreatitis on CT scan was admitted and found with 7,755 mg/dL triglycerides. She refers to have endometriosis for which she uses OCPs for >5years. She develops intractable abdominal pain along with abdominal distension and progress to Acute Respiratory Distress Syndrome (ARDS) requiring mechanical ventilation. She had a prolonged ICU stay and after management triglycerides decrease to 95mg/dL, symptoms resolve, and patient was discharge. 48y/o F with pancreatitis, lipase levels 1,452 U/L, amylase 744 U/L and positive imaging findings. Patient with uncontrolled diabetes (HgbA1c 11.0%) and breast mass s/p lumpectomy for which she used tamoxifen for the last 2 years. Triglycerides 7,444mg/dL on Gemfibrozil started due to previous levels found >4,000 mg/dL on outpatient evaluation. She deteriorates clinically and develops renal failure, abdominal compartment syndrome, respiratory distress and hypotension requiring mechanical ventilation and vasopressors. On repeated abdominal CT pancreas changes were suggestive of fulminant pancreatitis. Patient did not respond to treatment and passed away 48 hours after admission. Hypertriglyceridemia complications can be mild or fatal as in these cases. They were evaluated by a primary care physician before complications occur and had secondary causes that predispose them to hypertriglyceridemia, but they were not addressed, reason for which these scenarios raise concern of how much we know? How much we are doing to prevent these outcomes?... Awareness of hypertriglyceridemia management and adverse effects is necessary to avoid complications and fatal outcomes. Is time!
format Online
Article
Text
id pubmed-7207433
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-72074332020-05-13 SAT-567 Hypertriglyceridem...From Mild to Fatal!... Is Time for Awareness Cruz, Alegyari Figueroa Marin, Luis N Madera Ocasio, Lisselle M Villarrubia Molina Torres, Edwin O Irizarry De Jesus, Dariel J Rios, Alba D Rivera Vives, Alejandra N Santiago Bossolo, Alex N Gonzalez J Endocr Soc Cardiovascular Endocrinology Hypertriglyceridemia… From mild to fatal! … Is Time for Awareness. Hypertriglyceridemia can be primary or acquired. High triglycerides are related to complications such as pancreatitis and there is a positive correlation between hypertriglyceridemia and atherosclerotic burden. In this case series we aim to discuss pancreatitis as a hypertriglyceridemia complication and to acknowledge the importance of prevention and management. Is there something we can do to raise awareness and avoid complications as in the cases? All cases present with chief complaint of epigastric cramp-like abdominal pain, radiating to the back, nausea/vomiting and with highly lipemic blood samples. 38y/o F admitted after been found with lipase 268 U/L (n<60 U/L), amylase 131 U/L (n<100 U/L) and findings of pancreatitis on CT scan. Patient with one-year history of T2DM refers this is the 4(th) episode of pancreatitis and reports that last time she was told about having triglycerides in 4,000 mg/dL for which she went to her physician that prescribe her Fenofibrate. Patient triglycerides were 7,931 mg/dL (n<199 mg/dL) and found with poorly controlled diabetes with HgbA1c 8.4%. She was properly managed, and triglycerides decrease to 1,309 mg/dL. 31y/o F with elevated lipase (237 U/L, n<60 U/L) and findings of pancreatitis on CT scan was admitted and found with 7,755 mg/dL triglycerides. She refers to have endometriosis for which she uses OCPs for >5years. She develops intractable abdominal pain along with abdominal distension and progress to Acute Respiratory Distress Syndrome (ARDS) requiring mechanical ventilation. She had a prolonged ICU stay and after management triglycerides decrease to 95mg/dL, symptoms resolve, and patient was discharge. 48y/o F with pancreatitis, lipase levels 1,452 U/L, amylase 744 U/L and positive imaging findings. Patient with uncontrolled diabetes (HgbA1c 11.0%) and breast mass s/p lumpectomy for which she used tamoxifen for the last 2 years. Triglycerides 7,444mg/dL on Gemfibrozil started due to previous levels found >4,000 mg/dL on outpatient evaluation. She deteriorates clinically and develops renal failure, abdominal compartment syndrome, respiratory distress and hypotension requiring mechanical ventilation and vasopressors. On repeated abdominal CT pancreas changes were suggestive of fulminant pancreatitis. Patient did not respond to treatment and passed away 48 hours after admission. Hypertriglyceridemia complications can be mild or fatal as in these cases. They were evaluated by a primary care physician before complications occur and had secondary causes that predispose them to hypertriglyceridemia, but they were not addressed, reason for which these scenarios raise concern of how much we know? How much we are doing to prevent these outcomes?... Awareness of hypertriglyceridemia management and adverse effects is necessary to avoid complications and fatal outcomes. Is time! Oxford University Press 2020-05-08 /pmc/articles/PMC7207433/ http://dx.doi.org/10.1210/jendso/bvaa046.014 Text en © Endocrine Society 2020. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Cardiovascular Endocrinology
Cruz, Alegyari Figueroa
Marin, Luis N Madera
Ocasio, Lisselle M Villarrubia
Molina Torres, Edwin O
Irizarry De Jesus, Dariel J
Rios, Alba D Rivera
Vives, Alejandra N Santiago
Bossolo, Alex N Gonzalez
SAT-567 Hypertriglyceridem...From Mild to Fatal!... Is Time for Awareness
title SAT-567 Hypertriglyceridem...From Mild to Fatal!... Is Time for Awareness
title_full SAT-567 Hypertriglyceridem...From Mild to Fatal!... Is Time for Awareness
title_fullStr SAT-567 Hypertriglyceridem...From Mild to Fatal!... Is Time for Awareness
title_full_unstemmed SAT-567 Hypertriglyceridem...From Mild to Fatal!... Is Time for Awareness
title_short SAT-567 Hypertriglyceridem...From Mild to Fatal!... Is Time for Awareness
title_sort sat-567 hypertriglyceridem...from mild to fatal!... is time for awareness
topic Cardiovascular Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207433/
http://dx.doi.org/10.1210/jendso/bvaa046.014
work_keys_str_mv AT cruzalegyarifigueroa sat567hypertriglyceridemfrommildtofatalistimeforawareness
AT marinluisnmadera sat567hypertriglyceridemfrommildtofatalistimeforawareness
AT ocasiolissellemvillarrubia sat567hypertriglyceridemfrommildtofatalistimeforawareness
AT molinatorresedwino sat567hypertriglyceridemfrommildtofatalistimeforawareness
AT irizarrydejesusdarielj sat567hypertriglyceridemfrommildtofatalistimeforawareness
AT riosalbadrivera sat567hypertriglyceridemfrommildtofatalistimeforawareness
AT vivesalejandransantiago sat567hypertriglyceridemfrommildtofatalistimeforawareness
AT bossoloalexngonzalez sat567hypertriglyceridemfrommildtofatalistimeforawareness